Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

National Institutes of Health (NIH)

Status and phase: Completed; Phase 4

Conditions: Substance-Related Disorders; Cocaine-Related Disorders

Treatments: Drug: Methylphenidate

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00015301

Y01-5-0013-11

NIDA-5-0013-11

Details and patient eligibility

About

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Full description

The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Healthy normals

Exclusion criteria

History of head trauma or loss of consciousness. Significant medical history. History of seizures.